腫瘤醫療企業佰澤醫療通過聆訊
專注腫瘤醫療的佰澤醫療上周五(6日)通過聆訊,或於短期内開始招股,招銀國際為獨家保薦人。
Last Update:
8 6 月, 2025
Our site uses cookies. By using this site, you agree to the Privacy Policy and Terms of Use.